Experience of cosmonauts’ health monitoring shows that in the study of healthy subjects clinical approach to the evaluation of various…
A cardiac muscle performance assessment in terms of acid-alkaline balance has never been carried out before. The studies show it…
There are various indications for a mechanical circulatory support (MCS) devices implantation. We report a case of the use of…
The article considers the development of the periodic table of ECG phase changes which should reflect the variety of the…
Occurrence of HLA- and non-HLA antibodies after heart transplantation are associated with cardiac allograft vasculopathy
Cardiac allograft vasculopathy (CAV) accounts for major morbidity and mortality late in the heart transplant (HTx) history. The role of antibodies (Abs) directed against human leukocyte antigens (HLA) and non-HLA antigens in the pathogenesis of CAV are still under investigation.
Identification of non-HLA antibodies in ventricular assist device recipients
Recipients of ventricular assist devices (VADR) have a higher incidence to develop antibodies (Abs) against human leukocyte antigens (HLA). Non-HLA antibodies like major histocompatibility complex class I-related chain A (MICA) and autoantibodies against angiotensin type 1 receptor (AT1R) and endothelin receptor A (ETAR) are also implicated in the pathogenesis of acute rejection and allograft vasculopathy. We monitored non-HLA- and HLA-Abs in VADR up to one year after implantation.
UPCOMING ISSUE
Our book in WoS™ Core Collection
We are glad to inform you that the book "Theoretical principles of heart cycle phase analysis" written by researchers from Russian New University has been accepted and indexed in The Book Citation Index in Web of Science™ Core Collection
VIDEO ABOUT CARDIOMETRY
OUR PARTNERS
Your online partner for English language editing, proofreading, medical writing, formatting, design & development and publication support services